Curcumin induces ferroptosis in ovarian cancer cells through the Nrf2/GPX4 regulation axis [0.03%]
姜黄素通过Nrf2/GPX4调节轴诱导卵巢癌细胞铁死亡
Nan Liu,Ye-Ting Cui,Yi Zheng et al.
Nan Liu et al.
Ovarian cancer (OC) frequently develops acquired resistance to traditional anti-tumor treatments, highlighting the urgent need for novel therapeutic strategies. This study investigated whether curcumin can induce ferroptosis in OC cells thr...
microRNA-454 shows anti-angiogenic and anti-metastatic activity in pancreatic ductal adenocarcinoma by targeting LRP6 [Retraction] [0.03%]
MicroRNA-454通过靶向LRP6在胰腺导管腺癌中显示抗血管生成和抗转移活性[撤稿]
[This retracts the article on p. 139 in vol. 7, PMID: 28123855.]. AJCR Copyright © 2026.
A novel integrated inflammation response score (IIRS) for predicting all-cause and cardiovascular mortality among cancer survivors [0.03%]
一种新颖的整合炎症反应评分(IIRS)用于预测癌症幸存者的全因和心血管死亡率
Zhao Liu,Xiaojie Li,Zhaoxing Li
Zhao Liu
Systemic inflammation represents a crucial pathophysiological link between cancer, cardiovascular disease, and mortality, yet the predictive value of individual inflammatory indices is still unclear. The cohort study of 1,752 cancer survivo...
Erratum: IGF2BP2-modified UBE2D1 Interacts with Smad2/3 to Promote the Progression of Breast Cancer [0.03%]
IGF2BP2修饰的UBE2D1与Smad2/3相互作用促进乳腺癌进展（勘误）
Xiao-Qing Guan,Xiao-Ning Yuan,Kai-Xiang Feng et al.
Xiao-Qing Guan et al.
[This corrects the article on p. 2948 in vol. 13, PMID: 37560007.]. AJCR Copyright © 2026.
Published Erratum
American journal of cancer research. 2026 May 25;16(5):2097-2099. DOI:10.62347/CGDQ5129 2026
Establishment and validation of a 28-day clinical outcome prediction model for acute promyelocytic leukemia based on an early platelet-coagulation factor combined transfusion strategy [0.03%]
基于早期血小板-凝血因子联合输注策略的急性早幼粒细胞白血病28天临床预后预测模型的建立和验证
Shuaikui Zheng,Xiaocai Zheng,Zhanwei Li
Shuaikui Zheng
Early mortality in acute promyelocytic leukemia (APL) remains a major challenge, and the Sanz risk stratification has limited predictive value. This retrospective multicenter study aimed to establish and externally validate a 28-day mortali...
Clinical-pathological characteristics and prognosis of elderly primary liver cancer patients [0.03%]
老年原发性肝癌患者的临床病理特征及预后分析
Qun Li,Xiaomeng Cai
Qun Li
Primary liver cancer (PLC) is a highly malignant disease, with an increasing incidence among the elderly population. However, there is a lack of systematic evaluation regarding its progression, recurrence, and prognostic factors. This study...
Comparative efficacy of CDK4/6 inhibitors palbociclib, ribociclib, and abemaciclib in HR+/HER2- advanced breast cancer [0.03%]
CDK4/6抑制剂帕博西利、瑞博西利和阿贝西利治疗HR+/HER2-晚期乳腺癌的疗效比较
Bo Hou,Yu Zhang
Bo Hou
This study aimed to explore the clinical efficacy of palbociclib, ribociclib, and abemaciclib in hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC) and to identify factors i...
A novel therapeutic avenue: pharmacological induction of tumor cell pyroptosis [0.03%]
新颖的治疗途径：药物诱导肿瘤细胞焦亡疗法
Katherine J Young,Zijun Y Xu-Monette
Katherine J Young
Emerging preclinical evidence indicates that pharmacological induction of tumor pyroptosis promotes immune responses, representing a new therapeutic avenue for relapsed/refractory cancer patients. For example, a recent study in Communicatio...
Preoperative nomogram for predicting microvascular invasion and stratifying recurrence risk in early-stage hepatocellular carcinoma [0.03%]
用于预测早期肝细胞癌微血管侵犯及复发风险的术前列线图模型
Zhi-Cheng Guo,Lian Li,Zhang-Neng Yu et al.
Zhi-Cheng Guo et al.
Microvascular invasion (MVI) is a key determinant of early recurrence and poor prognosis in hepatocellular carcinoma (HCC). However, it can only be diagnosed pathologically after surgery, making reliable preoperative prediction challenging....
Neoadjuvant chemotherapy followed by limb-sparing surgery for osteosarcoma: a retrospective cohort study on efficacy, safety, and prognostic factors [0.03%]
新辅助化疗结合保留肢体手术治疗骨肉瘤的疗效、安全性及其预后因素的一项回顾性队列研究
Min Yi,Kai Zheng,Hui Ma et al.
Min Yi et al.
This retrospective study evaluated the outcomes of neoadjuvant chemotherapy (NACT) combined with limb-sparing surgery (LSS) for osteosarcoma (OS). A total of 204 OS patients treated at West China Hospital, Sichuan University between Februar...